AllPennyStocks.com Spotlights Benda Pharmaceutical, Inc.


MISSISSAUGA, Ontario, Sept. 25, 2007 (PRIME NEWSWIRE) -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com), a leading penny stock/small-cap information site, released its latest spotlight company Benda Pharmaceutical, Inc. (OTCBB:BPMA).

Benda Pharmaceutical, Inc., a China-based pharmaceutical company, is a pure play on explosive Chinese pharmaceutical spending and the global search for a cancer cure. Benda produces conventional and Traditional Chinese Medicines, as well as Gendicine(r), the world's first commercialized gene therapy medicine for the treatment of cancer.

Gendicine(r) is expected to generate $12.0 million in revenue in 2007, increasing to $20.8 million in 2008. Benda Pharmaceutical, Inc. with all its subsidiaries is anticipating revenues in 2007 of $40.7 million, which is expected to jump to $76.2 million in 2008.

A complete BPMA profile can be viewed at: http://www.allpennystocks.com/aps_us/company_spotlights/archives/bpma.asp

About AllPennyStocks.com Media Inc.:

AllPennyStocks.com is focused on the small-cap/penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and U.S. site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs weekly penny stocks to watch, has a daily market write-up, provides company spotlights, runs a unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, Nasdaq and OTCBB, and much more information for the average investor.

Although the majority of AllPennyStocks.com reports are independent, it has received compensation for carrying the report on Benda Pharmaceutical, Inc. (OTCBB:BPMA); the amount is seventeen thousand seven hundred and fifty dollars by the company for its efforts in presenting the BPMA profile on its web site and distributing it to its database of subscribers as well as other services. This creates an inherent conflict of interest and readers are encouraged to view the full disclaimer at http://www.allpennystocks.com/aps_us/company_spotlights/archives/bpma.asp.



            

Mot-clé


Coordonnées